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Abstract: Nephrogenic diabetes insipidus (NDI) is caused by an improper response of the kidney to the
antidiuretic hormone arginine vasopressin (AVP), leading to a decreased ability to concentrate urine which
results in polyuria and polydipsia. The clinical diagnosis of NDI relies on demonstration of subnormal
ability to concentrate urine despite the presence of AVP. NDI is most commonly acquired, secondary
to kidney disorders, electrolyte imbalance and various drugs. Congenital forms of NDI are rare, and
most commonly inherited in a X-linked manner with mutations of the AVP receptor type 2 (AVPR2).
Mutations of the water channel aquaporin-2 (AQP2) can be detected in autosomal recessive or dominant
forms of NDI. Management of NDI should focus on free access to drinking water and reduction of polyuria.
= Le diabète insipide néphrogénique (DIN) est causé par une réponse inappropriée du rein à l’hormone
antidiurétique (ADH), entraînant une diminution de la capacité de concentrer l’urine, se manifestant par
l’association polyurie et polydipsie. Le diagnostic clinique de DIN repose sur la démonstration du défaut
de concentration de l’urine malgré la présence d’ADH. Le DIN est le plus souvent acquis, suite à diverses
maladies rénales, troubles ioniques, ou médicaments. Les formes congénitales de DIN sont rares, le plus
souvent liées au chromosome X en relation avec des mutations du récepteur de l’ADH de type 2 (gène
AVPR2). Des mutations du gène AQP2 codant pour le canal à eau aquaporine-2 sont retrouvées dans
les formes transmises sur un mode dominant ou récessif. Le traitement du DIN vise à maintenir l’accès
à l’eau potable et à réduire la polyurie.
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Nephrogenic diabetes insipidus (NDI) is caused by an improper response of the kidney to the 
antidiuretic hormone arginine vasopressin (AVP), leading to a decrease in the ability to concentrate 
urine by removing free water in the distal nephron. This results in polyuria (excessive urine 
production, which can reach up to 10L a day in children) and polydipsia (excessive thirst). Infants 
affected by the inherited forms of the disease usually show failure to thrive, fever, constipation, and 
episodes of severe hypernatremic dehydration with risk of neurological sequels. Short stature and 
secondary dilatation of the ureters and bladder from the high urine volume is common (1,2).  
The clinical diagnosis of NDI relies on demonstration of subnormal ability to concentrate urine 
despite the presence of AVP. Differential diagnosis includes neurogenic/central diabetes insipidus 
(lack of AVP), psychogenic polydipsia (compulsive water drinking) and diabetes mellitus (polyuria due 
to glucosuria). The diagnosis relies on the simultaneous measurement of sodium concentration (or 
osmolality) in plasma and urine: increased plasma sodium (> 145 mEq/L) or osmolality (> 290 
mOsm/kg)  in the presence of diluted urine is suggestive of NDI. The differential diagnosis can also be 
made by using the water deprivation test and/or administration of DDAVP (desmopressin) 
intranasally. If the patient is able to concentrate urine following administration of DDAVP, then the 
cause of the diabetes insipidus is neurogenic; if no response occurs to DDAVP administration, then 
the cause is likely to be nephrogenic (1,2). 
NDI is most commonly acquired, secondary to kidney disorders such as polycystic kidney disease, 
amyloidosis, sickle cell disease, granulomatous diseases, chronic infection, urinary tract obstruction, 
Sjögren syndrome, vascular disorders, electrolyte imbalance (hypokalemia, hypercalcemia) and 
various drugs (lithium, amphotericin B, orlistat, ifosfomide, ofloxacin, cidofovir, vaptans, etc...) (3). 
Congenital forms of NDI are rare, with a prevalence estimated at 1-2/1 000 000. Congenital NDI is 
most commonly inherited in a X-linked manner (~90% of individuals), in relation with mutations of 
the AVP receptor type 2 (AVPR2). NDI can also be inherited in an autosomal recessive manner (~9% 
of individuals) or in an autosomal dominant manner (~1% of individuals), in relation with muations of 
the water channel aquaporin-2 (AQP2). Molecular genetic testing of the two genes associated with 
NDI (AQP2 and AVPR2) is clinically available (2,4,5).  
Management of NDI should focus on free access to drinking water and reduction of polyuria by using 
thiazide diuretics and/or potassium-sparing diuretic (amiloride), dietary restriction of sodium, and 
nonsteroidal anti-inflammatory drugs (NSAIDs). Patients with congenital NDI should be monitored for 
growth, serum sodium concentration and hydration status, and development of hydronephrosis 
(renal ultrasound).  
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Nephrogenic diabetes insipidus (NDI) is caused by an improper response of the kidney to the 
antidiuretic hormone arginine vasopressin (AVP), leading to a decreased ability to concentrate urine 
which results in polyuria and polydipsia. The clinical diagnosis of NDI relies on demonstration of 
subnormal ability to concentrate urine despite the presence of AVP. NDI is most commonly acquired, 
secondary to kidney disorders, electrolyte imbalance and various drugs. Congenital forms of NDI are 
rare, and most commonly inherited in a X-linked manner with mutations of the AVP receptor type 2 
(AVPR2). Mutations of the water channel aquaporin-2 (AQP2) can be detected in autosomal recessive 
or dominant forms of NDI. Management of NDI should focus on free access to drinking water and 
reduction of polyuria. 
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Résumé 
Le diabète insipide néphrogénique (DIN) est causé par une réponse inappropriée du rein à l'hormone 
antidiurétique (ADH), entraînant une diminution de la capacité de concentrer l'urine, se manifestant 
par l'association polyurie et polydipsie. Le diagnostic clinique de DIN repose sur la démonstration du 
défaut de concentration de l'urine malgré la présence d'ADH. Le DIN est le plus souvent acquis, suite 
à diverses maladies rénales, troubles ioniques, ou médicaments. Les formes congénitales de DIN sont 
rares, le plus souvent liées au chromosome X en relation avec des mutations du récepteur de l'ADH 
de type 2 (gène AVPR2). Des mutations du gène AQP2 codant pour le canal à eau aquaporine-2 sont 
retrouvées dans les formes transmises sur un mode dominant ou récessif. Le traitement du DIN vise 
à maintenir l'accès à l'eau potable et à réduire la polyurie. 
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